Last update:
Why brain cells learn better: NMDA receptor maps may explain memory-linked calcium flow
The human brain constantly adapts in response to experiences, forming new connections between neurons and reorganizing existing ones. The brain's ability to adapt in response to experiences is known as neuroplasticity.
10 hours ago
0
6
A new way to recharge aging muscle stem cells by restoring a key metabolic component
Losing muscle strength is a natural part of aging. At the core of this decline is a drop in the number of muscle stem cells (MuSCs), the specialized cells responsible for maintaining and regenerating muscle tissue throughout ...
8 hours ago
0
6
Medical research news
Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The study, published in Nature ...
7 hours ago
0
2
Baseline MRI lets AI predict Alzheimer's progression without cognitive testing
Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of Alzheimer's disease progression, ...
7 hours ago
0
1
Nutrition support during pregnancy improves birth outcomes, global study finds
In parts of the world where daily nutrition is unstable, pregnancy and newborn health are more precarious. A recent study led by epidemiologist Dongqing Wang of the George Mason University College of Public Health adds to ...
8 hours ago
0
2
By age 4, one side of the brain is already calling the shots on language
The brain's capacity to use and understand language expands rapidly in the first years of life, as babies start to make sense of the words they hear and eventually begin to piece together sentences of their own. The language-processing ...
6 hours ago
0
0
Prehospital trauma care gets flexible option as whole blood matches components in nationwide trial
Giving whole blood or the component parts of blood are equally effective options for paramedics and emergency medical technicians to use in treating patients with severe, traumatic bleeding before arriving at the hospital, ...
8 hours ago
0
1
How looking through static can help people with a common degenerative disease see better
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness among aging people globally. Around one in seven Australians over the age of 50 have some signs of AMD.
9 hours ago
0
1
A protective gel for a future without insulin injections
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing ...
12 hours ago
0
7
How chemotherapy can backfire: An immune shift tied to tumor resistance and poorer outcomes
Chemotherapy can be life-saving for many patients, but not all tumors respond—and some that do, may eventually become resistant. Investigators at Houston Methodist have identified a possible explanation for this resistance, ...
5 hours ago
0
0
Age does not appear to drive cardiovascular risk in pregnancy
Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research. The findings ...
11 hours ago
0
3
Written in the eye: How the retina's biological age could help predict osteoporosis risk
Eyes, the high-resolution biological devices that help us visualize the outside world, are now being used as a portal to assess our internal health. Scientists have found that a closer evaluation of how one's retina is aging ...
'Garbage collectors' of the brain grind to a halt in fatal multiple system atrophy
Multiple system atrophy (MSA) is a rare and fatal brain disorder with no available treatment or cure, attacking the nervous system, balance, and the ability to move. The disease in many ways resembles Parkinson's disease, ...
12 hours ago
0
5
Statistical method may overstate Alzheimer's drugs' cognitive benefits by 29 times
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.
12 hours ago
0
5
Medicare Advantage broker payments potentially hit $10 billion annually, study finds
New research offers one of the clearest pictures yet on just how large the Medicare Advantage insurance broker market has become. Published as a research letter in JAMA Internal Medicine, the study by health policy scholars ...
12 hours ago
0
4
Once-nightly pill treats causes of airway collapse to control obstructive sleep apnea in large clinical trial
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to treat OSA by addressing ...
16 hours ago
0
30
New drug target identified for Fragile X syndrome
UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly one in 2,000 boys.
12 hours ago
0
3
AI-powered CPR coach outperforms 911 dispatchers in guiding bystander resuscitation
A new study from scientists at the University of California San Diego in collaboration with the University of Pittsburgh School of Medicine, Johns Hopkins University, and other institutions, demonstrates that an artificial ...
12 hours ago
0
3
Why an off-label autism drug suddenly took off, despite limited large-scale evidence
Researchers from the University of California San Diego found that prescriptions for leucovorin, a drug sometimes used off-label for autism spectrum disorder (ASD), rose sharply among children after widespread media attention ...
12 hours ago
0
3
At 'most favored nation' prices, can Medicare break even on GLP-1 drugs?
In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...
6 hours ago
0
0
